Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer.

[1]  J. B. Moody,et al.  Diffusion imaging for evaluation of tumor therapies in preclinical animal models , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[2]  R. Gillies,et al.  Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. , 2004, Neoplasia.

[3]  Michal Neeman,et al.  Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker. , 2004, Neoplasia.

[4]  Stephan E Maier,et al.  Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. , 2004, Neoplasia.

[5]  T. Chenevert,et al.  Modeled Temporal Responses of Tumor Volume and ADC to Anticancer Therapy , 2004 .

[6]  Alexander de Vries,et al.  Preliminary Results on the Influence of Chemoradiation on Apparent Diffusion Coefficients of Primary Rectal Carcinoma Measured by Magnetic Resonance Imaging , 2003, Strahlentherapie und Onkologie.

[7]  Jürgen Griebel,et al.  Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. , 2003, International journal of radiation oncology, biology, physics.

[8]  Bradford A Moffat,et al.  Evaluation of cancer therapy using diffusion magnetic resonance imaging. , 2003, Molecular cancer therapeutics.

[9]  Jürgen Griebel,et al.  Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. , 2003, European journal of radiology.

[10]  A R Padhani,et al.  Functional MRI for anticancer therapy assessment. , 2002, European journal of cancer.

[11]  C. Meyer,et al.  Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. , 2002, Molecular imaging.

[12]  Ning-Yu An,et al.  Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[13]  Jan Wolber,et al.  Diffusion MRI for prediction of response of rectal cancer to chemoradiation , 2002, The Lancet.

[14]  A. Padhani,et al.  Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging , 2002, NMR in biomedicine.

[15]  Risto A Kauppinen,et al.  Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy , 2002, NMR in biomedicine.

[16]  Jean-Philippe Galons,et al.  Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. , 2002, Neoplasia.

[17]  J. M. Taylor,et al.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.

[18]  Olav Haraldseth,et al.  Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging , 2000, Magnetic resonance in medicine.

[19]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[20]  R. Gillies,et al.  Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. , 1999, Neoplasia.

[21]  T L Chenevert,et al.  Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.